@Elekta 11 months ago
As the demand for cancer care rises, personalized medicine and what this means for people with #cancer continues to be a key issue. We’d like to thank @sweden2023eu for inviting our CEO Gustaf Salford to participate in a panel on #bigdata, its challenges and the promise it… https://twitter.com/i/web/status/1673693176886878212 https://t.co/ilXJC0F4Zw
@xconomy.com 3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com 4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More